Positive NANOG expression showed to be a significant risk factor for poorer overall survival in esophageal adenocarcinoma (HR = 1.40, 95% CI = 1.09–1.80, p = 0.006, Table 2). This evidence concerns the gene NANOG and esophageal adenocarcinoma.